Cargando…
STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
SIMPLE SUMMARY: STAT3, an oncogene, contributes to insensitivity of chemotherapy and radiotherapy in tumor, reduces the clinical efficacy. Meanwhile, STAT3β, a STAT3 splicing isoform, is related to the inhibition of tumor growth and chemosensitivity. STAT3 may become a potential target to overcome t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564975/ https://www.ncbi.nlm.nih.gov/pubmed/32872659 http://dx.doi.org/10.3390/cancers12092459 |